ENANTA PHARMACEUTICALS, INC Paid-in-Kind Interest
ENANTA PHARMACEUTICALS, INC (ENTA) reported Paid-in-Kind Interest of $6.00 thousand for the 9-month period ending 2015-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2016-08-09
- ENANTA PHARMACEUTICALS, INC paid-in-kind interest for the quarter ending 2015-06-30 was $2.00K, a 60.00% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC paid-in-kind interest for the quarter ending 2015-03-31 was $2.00K, a 50.00% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC paid-in-kind interest for the quarter ending 2014-12-31 was $2.00K, a 60.00% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC paid-in-kind interest for the quarter ending 2014-09-30 was -$6.00K, a 175.00% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC paid-in-kind interest for fiscal 2014 was $8.00K, a 74.19% decline from fiscal 2013.
- ENANTA PHARMACEUTICALS, INC paid-in-kind interest for fiscal 2013 was $31.00K.
- ENANTA PHARMACEUTICALS, INC paid-in-kind interest for fiscal 2011 was $2.06M.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2015-06-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $4.00K derived: sum of 2 quarters · filed 2016-08-09 | $6.00K 10-Q · filed 2016-08-09 | $0.00 derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-03-31 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | $4.00K 10-Q · filed 2016-05-10 | -$2.00K derived: sum of 3 quarters · filed 2016-05-10 | $3.00K derived: sum of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | $2.00K 10-Q · filed 2016-02-09 | -$4.00K derived: sum of 2 quarters · filed 2016-02-09 | $1.00K derived: sum of 3 quarters · filed 2016-02-09 | $5.00K derived: sum of 4 quarters · filed 2016-02-09 |
| 2014-09-30 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | -$1.00K derived: sum of 2 quarters · filed 2015-12-11 | $3.00K derived: sum of 3 quarters · filed 2015-12-11 | $8.00K 10-K · filed 2015-12-11 |
| 2014-06-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | $9.00K derived: sum of 2 quarters · filed 2015-08-10 | $14.00K 10-Q · filed 2015-08-10 | $22.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2014-03-31 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | $9.00K 10-Q · filed 2015-05-08 | $17.00K derived: sum of 3 quarters · filed 2015-12-11 | $24.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-12-31 | $5.00K 10-Q · filed 2015-02-06 | $13.00K derived: sum of 2 quarters · filed 2015-12-11 | $20.00K derived: sum of 3 quarters · filed 2015-12-11 | |
| 2013-09-30 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $15.00K derived: sum of 2 quarters · filed 2015-12-11 | $31.00K 10-K · filed 2015-12-11 | |
| 2013-06-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | $23.00K 10-Q · filed 2014-08-12 | ||
| 2013-03-31 | $16.00K 10-Q · filed 2014-05-12 | |||
| 2011-09-30 | $2.06M 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |